On behalf of the Journal of Immune Disorder and Therapy : Open Access, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, we are privileged to welcome clinical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of immune disorder and therapy: Open Access.

The Journal of Immune Disorder and Therapy : Open Access aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Cancer. The open access journal is published by Insight medical publishing that hosts open access peer-reviewed journals as well as organizes more than 17 Years of Life science Communication in International scientific Conferences.

Treatment for immunodeficiency disorders commonly includes antibiotics and immunoglobulin therapy. Other antiviral drugs, amantadine and acyclovir, or a drug called interferon are used for treatment of the viral infections caused by immunodeficiency disorders.

This is the longest running independent life science events company with a predominantly academic client base. Our multi professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

Warm Regards,

Sofia Khan

Journal Coordinator

Journal of Immune Disorder & Therapy

Email:- immunedis@escientificjournals.com

What’s app No- +3225889658